Clinical Trial

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-892216-LAI in healthy adults.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-07-23; most recent amendment 2025-08-20.
Status change: Not Yet Recruiting → Recruiting 2025-07-30
Trial Details
NCT Number NCT07093580
Lead Sponsor Shionogi
Conditions Healthy Participants
Enrollment 98 participants
Start Date 2025-07-29
Primary Completion 2027-05-26 (estimated)
Study Completion 2027-05-26 (estimated)
Updated on ClinicalTrials.gov 2025-08-27